1. Market Research
  2. > Cancer Industry

Leukemia Industry, December 2016 Market Reports from Top Publishers

You might be interested in: Molecular Diagnostic, Diagnostics, Cancer, Therapy, Pap Smear, Blood Supply, Blood Disease, Infectious Disease, Transplantation, Bone Marrow Transplant, Cancer Diagnostic, Analgesic, Anti-Infective, Banking, Biopharmaceutical, Biopsy, Cell Therapy, Clinical Trial, Cloud Computing, In Vitro Diagnostic Reagent.


 
1-10 of about 400 reports for Leukemia

Purchase Reports From Reputable Market Research Publishers

Iclusig - ponatinib - Oncology drug report - 2013-2015 analysis; 2016-2021 expectations

Iclusig - ponatinib - Oncology drug report - 2013-2015 analysis; 2016-2021 expectations

  • $ 300
  • Industry report
  • December 2016
  • by Cancer Research Analytics

“Iclusig - ponatinib - Oncology drug report - 2013-2015 analysis; 2016-2021 expectations” is a comprehensive drug report on the most controversial drug in recent times. Iclusig is the first and only ...

Leukemia Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Leukemia Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • December 2016
  • by Global Data

Leukemia Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Leukemia Diagnostic Tests - Medical Devices Pipeline Assessment, 2016" provides ...

Anaplastic Oligoastrocytoma - Pipeline Review, H2 2016

Anaplastic Oligoastrocytoma - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Anaplastic Oligoastrocytoma - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anaplastic Oligoastrocytoma – Pipeline Review, H2 2016, ...

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Lymphocytic Leukemia (CLL) – Pipeline ...

Myelodysplastic Syndrome - Pipeline Review, H2 2016

Myelodysplastic Syndrome - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Myelodysplastic Syndrome - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myelodysplastic Syndrome – Pipeline Review, H2 2016, provides ...

Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2016

Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Refractory Acute Myeloid Leukemia – Pipeline Review, ...

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2016

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Myelocytic Leukemia ...

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Refractory Chronic Lymphocytic Leukemia ...

Global and Chinese Leukemia Therapeutics Industry, 2016 Market Research Report

Global and Chinese Leukemia Therapeutics Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese Leukemia Therapeutics Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global Leukemia Therapeutics industry with ...

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2000
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about ...

About 7000 reports for Leukemia

Download Unlimited Documents from Trusted Public Sources

Leukemia Statistics in the US

  • January 2016
    147 pages
  • Leukemia  

  • United States  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.